Potential of growth hormone-releasing hormone antagonists (JV-1-36 and JV-1-42) for the treatment of brain tumours.
Doggrell
Sheila A
SA
Division of Health Practice, Auckland University of Technology--Akoranga Campus, Northcote, Auckland, New Zealand. s.doggrell@xtra.co.nz
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D013007:Growth Hormone-Releasing Hormone / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans
D000970:Antineoplastic Agents; C403071:JV 1-36; D013007:Growth Hormone-Releasing Hormone